1. Home
  2. MTH vs GALT Comparison

MTH vs GALT Comparison

Compare MTH & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Meritage Homes Corporation

MTH

Meritage Homes Corporation

HOLD

Current Price

$66.28

Market Cap

5.1B

ML Signal

HOLD

Logo Galectin Therapeutics Inc.

GALT

Galectin Therapeutics Inc.

HOLD

Current Price

$4.14

Market Cap

261.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MTH
GALT
Founded
1985
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1B
261.1M
IPO Year
1988
N/A

Fundamental Metrics

Financial Performance
Metric
MTH
GALT
Price
$66.28
$4.14
Analyst Decision
Buy
Strong Buy
Analyst Count
8
3
Target Price
$82.75
$8.50
AVG Volume (30 Days)
751.1K
812.7K
Earning Date
01-28-2026
11-14-2025
Dividend Yield
2.59%
N/A
EPS Growth
N/A
N/A
EPS
7.50
N/A
Revenue
$6,043,594,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$5.61
N/A
P/E Ratio
$8.86
N/A
Revenue Growth
N/A
N/A
52 Week Low
$59.27
$0.94
52 Week High
$84.74
$7.13

Technical Indicators

Market Signals
Indicator
MTH
GALT
Relative Strength Index (RSI) 38.75 36.46
Support Level $65.33 $3.90
Resistance Level $67.33 $4.19
Average True Range (ATR) 1.48 0.54
MACD -0.40 -0.18
Stochastic Oscillator 14.65 17.50

Price Performance

Historical Comparison
MTH
GALT

About MTH Meritage Homes Corporation

Meritage Homes Corp is engaged as a designer and builder of single-family attached and detached homes. It has operations in three regions: West, Central, and East, comprising ten states: Arizona, California, Colorado, Texas, Florida, Georgia, North Carolina, South Carolina, Tennessee, and Utah. The company operates with two principal business segments: homebuilding and financial services. The homebuilding segments are engaged in the business of acquiring and developing land, constructing homes, marketing and selling those homes, and providing warranty and customer services, and the financial services segment offers title and escrow, mortgage, and insurance services. The company generates key revenue from the homebuilding segment.

About GALT Galectin Therapeutics Inc.

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.

Share on Social Networks: